Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
7.03
+0.06 (0.86%)
At close: Sep 11, 2026, 4:00 PM EDT
7.03
0.00 (0.06%)
After-hours: Sep 11, 2026, 7:37 PM EDT
Exagen Market Cap
Exagen has a market cap or net worth of $170.3 million as of September 11, 2026. Its market cap has decreased by -19.63% in one year.
Market Cap
170.30M
Enterprise Value
173.37M
1-Year Change
-19.63%
Ranking
Category
Stock Price
$7.03
ChartMarket Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $170.30M, an increase of 169.87%. That is a compound annual growth rate of 15.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 170.30M | 23.60% |
| Dec 31, 2025 | 137.79M | 90.55% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Freenome | 1.59B |
| OPKO Health | 1.11B |
| Castle Biosciences | 987.36M |
| Fulgent Genetics | 553.61M |
| Myriad Genetics | 321.38M |
| Biodesix | 274.75M |
| Insight Molecular Diagnostics | 130.24M |
| Burning Rock Biotech | 122.55M |